Tags

Type your tag names separated by a space and hit enter

[Pneumonia in immunocompromised patients: the value of non-biopsy bronchoscopic examination procedures in the diagnosis of pathogens].
Klin Wochenschr. 1990 Apr 02; 68(7):372-9.KW

Abstract

Bronchoscopy was performed on 101 immunocompromised patients with fever and pulmonary infiltrates. Underlying diseases were mainly hematological malignancies. In 71% of cases, etiology of pneumonia was clarified by nonbioptic bronchoscopic methods (bronchoalveolar lavage, bronchial secretions, protected specimen brush). In 51% of cases, empirical antibiotic treatment was modified following bronchoscopy. In patients with early bronchoscopy a better prognosis regarding healing and survival was observed than in those cases, where bronchoscopy was performed later during pneumonia. Bronchoalveolar lavage was particularly suited for diagnosis of Pneumocystis carinii and pneumonia due to viruses or Legionella. Sensitivity and specificity of bronchoscopy were lower for diagnosis of mycotic pneumonia and of Gram-negative or Gram-positive bacteria.

Authors+Show Affiliations

Medizinische Klinik, Westfälischen Wilhelms-Universität Münster.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

2160559

Citation

von Eiff, M, et al. "[Pneumonia in Immunocompromised Patients: the Value of Non-biopsy Bronchoscopic Examination Procedures in the Diagnosis of Pathogens]." Klinische Wochenschrift, vol. 68, no. 7, 1990, pp. 372-9.
von Eiff M, Steimann R, Roos N, et al. [Pneumonia in immunocompromised patients: the value of non-biopsy bronchoscopic examination procedures in the diagnosis of pathogens]. Klin Wochenschr. 1990;68(7):372-9.
von Eiff, M., Steimann, R., Roos, N., van Husen, N., Walger, P., Baumgart, P., Fegeler, W., Junge, E., Baumeister, H., & Wilms, B. (1990). [Pneumonia in immunocompromised patients: the value of non-biopsy bronchoscopic examination procedures in the diagnosis of pathogens]. Klinische Wochenschrift, 68(7), 372-9.
von Eiff M, et al. [Pneumonia in Immunocompromised Patients: the Value of Non-biopsy Bronchoscopic Examination Procedures in the Diagnosis of Pathogens]. Klin Wochenschr. 1990 Apr 2;68(7):372-9. PubMed PMID: 2160559.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Pneumonia in immunocompromised patients: the value of non-biopsy bronchoscopic examination procedures in the diagnosis of pathogens]. A1 - von Eiff,M, AU - Steimann,R, AU - Roos,N, AU - van Husen,N, AU - Walger,P, AU - Baumgart,P, AU - Fegeler,W, AU - Junge,E, AU - Baumeister,H, AU - Wilms,B, PY - 1990/4/2/pubmed PY - 1990/4/2/medline PY - 1990/4/2/entrez SP - 372 EP - 9 JF - Klinische Wochenschrift JO - Klin Wochenschr VL - 68 IS - 7 N2 - Bronchoscopy was performed on 101 immunocompromised patients with fever and pulmonary infiltrates. Underlying diseases were mainly hematological malignancies. In 71% of cases, etiology of pneumonia was clarified by nonbioptic bronchoscopic methods (bronchoalveolar lavage, bronchial secretions, protected specimen brush). In 51% of cases, empirical antibiotic treatment was modified following bronchoscopy. In patients with early bronchoscopy a better prognosis regarding healing and survival was observed than in those cases, where bronchoscopy was performed later during pneumonia. Bronchoalveolar lavage was particularly suited for diagnosis of Pneumocystis carinii and pneumonia due to viruses or Legionella. Sensitivity and specificity of bronchoscopy were lower for diagnosis of mycotic pneumonia and of Gram-negative or Gram-positive bacteria. SN - 0023-2173 UR - https://www.unboundmedicine.com/medline/citation/2160559/[Pneumonia_in_immunocompromised_patients:_the_value_of_non_biopsy_bronchoscopic_examination_procedures_in_the_diagnosis_of_pathogens]_ DB - PRIME DP - Unbound Medicine ER -